Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

R. Hughes; R. Del Olmo; B. Make; D. Price; A. Agustí; E. Rapsomaniki; H. Müllerová; J. Vestbo

Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

R. Hughes^* (Corresponding Author), R. Del Olmo, B. Make, D. Price, A. Agustí, E. Rapsomaniki, H. Müllerová, J. Vestbo

^*Corresponding author for this work

Research output: Contribution to conference › Abstract › peer-review

Abstract

Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with a physician-assigned diagnosis of asthma and/or COPD. Pre- and post-bronchodilator (BD) spirometry was performed at baseline. Objective: To compare spirometric markers of airflow obstruction and reversibility across the spectrum of obstructive lung disease.

Original language	English
Publication status	Accepted/In press - 27 Jul 2020
Event	30th ERS International Congress - Virtual Event Duration: 7 Sep 2020 → 9 Sep 2020

Conference

Conference	30th ERS International Congress
Period	7/09/20 → 9/09/20

Cite this

@conference{4f370ccc560a40c796811348ee6d9a04,

title = "Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY",

abstract = "Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with a physician-assigned diagnosis of asthma and/or COPD. Pre- and post-bronchodilator (BD) spirometry was performed at baseline. Objective: To compare spirometric markers of airflow obstruction and reversibility across the spectrum of obstructive lung disease. ",

author = "R. Hughes and {Del Olmo}, R. and B. Make and D. Price and A. Agust{\'i} and E. Rapsomaniki and H. M{\"u}llerov{\'a} and J. Vestbo",

year = "2020",

month = jul,

day = "27",

language = "English",

note = "30th ERS International Congress ; Conference date: 07-09-2020 Through 09-09-2020",

}

TY - CONF

T1 - Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

AU - Hughes, R.

AU - Del Olmo, R.

AU - Make, B.

AU - Price, D.

AU - Agustí, A.

AU - Rapsomaniki, E.

AU - Müllerová, H.

AU - Vestbo, J.

PY - 2020/7/27

Y1 - 2020/7/27

N2 - Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with a physician-assigned diagnosis of asthma and/or COPD. Pre- and post-bronchodilator (BD) spirometry was performed at baseline. Objective: To compare spirometric markers of airflow obstruction and reversibility across the spectrum of obstructive lung disease.

AB - Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with a physician-assigned diagnosis of asthma and/or COPD. Pre- and post-bronchodilator (BD) spirometry was performed at baseline. Objective: To compare spirometric markers of airflow obstruction and reversibility across the spectrum of obstructive lung disease.

M3 - Abstract

T2 - 30th ERS International Congress

Y2 - 7 September 2020 through 9 September 2020

ER -

Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

Abstract

Conference

Fingerprint

Cite this